James Murphy

The folder contains a copy of his transcript, also 1 audio tape. The interview refers to: * his work at the company from 1940-1980; began in standards control carrying out routine analysis of drugs; wartime work; Tuckahoe. * drugs - mainly on Digoxin, also mentions various other products inc, Kepler and Dexin ("the baby product"). Includes *a reprint from The Lancet June 1973 'Correlation of Digoxin-Tablet Dissolution-Rate with Biological Availability' by John Lindenbaum, Cincent Butler, James Murphy and Ronald Cresswell. * an internal report on history of Digoxin produciton * a reprint from the Journal of American Pharmaceutical Association Feb 1971 'Burroughs Wellcome Moves to North Carolina'

2 items

Copyright was assigned to the Wellcome Trust for all material created or commissioned by the Wellcome Foundation, its successors and associated companies. The copyright in third party material (ie material not created by WF such as letters and publications from external sources, magazine articles, newspaper cuttings etc) is assumed to remain with the creator or his/her heirs. Where third party material exists, this has been noted at item level.

This item is restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2053.